UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000012385 |
|---|---|
| Receipt number | R000014482 |
| Scientific Title | Prospective study to examine the polyp detection rate positive effect by colonoscopy using Endocuff, and small intestinal transit time shortening effect of Niflec versus Moviprep in colon capsule endoscopy. |
| Date of disclosure of the study information | 2013/11/22 |
| Last modified on | 2016/03/12 10:53:28 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Prospective study to examine the polyp detection rate positive effect by colonoscopy using Endocuff, and small intestinal transit time shortening effect of Niflec versus Moviprep in colon capsule endoscopy.
Acronym
Colon Capsule 2013
Scientific Title
Prospective study to examine the polyp detection rate positive effect by colonoscopy using Endocuff, and small intestinal transit time shortening effect of Niflec versus Moviprep in colon capsule endoscopy.
Scientific Title:Acronym
Colon Capsule 2013
Region
| Japan |
Condition
Condition
The patient who have colonoscopy.
Classification by specialty
| Gastroenterology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Positive effect of polyp detection rate by colonoscopy using Endocuff, and standardization of treatment before the colon capsule endoscopy in Japanese.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
1. Transit time of total tract of the colon capsule endoscope (small intestine transit time).
2. Positive effect of polyp detection rate by colonoscopy using Endocuff.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Prevention
Type of intervention
| Medicine |
Interventions/Control_1
Niflec
Interventions/Control_2
Moviprep
Interventions/Control_3
Water
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 40 | years-old | <= |
Age-upper limit
| 75 | years-old | > |
Gender
Male and Female
Key inclusion criteria
1. The patient's age is between 40 and 74 years old.
2. Informed Consent.
Key exclusion criteria
1. Patients who may have been stenosed or occluded lesion of gastrointestinal tract.
2. Patients who have been diagnosed from the beginning that there is a colon lesion.
3. Patients who may have been lower gastrointestinal tract diseases such as melena and diarrhea.
4. Patients with severe renal failure, liver failure, circulatory failure.
5. Patients who are pregnant, suspected to be pregnant or breastfeeding.
6. Patients with drug allergy and/or history of severe side effects due to analgesic and/or sedatives.
7. Patients who are judged to be difficult treatment for complications.
8. Stop of this study.
9. Patients who are considered to be inapproriate by the investigators.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Masakatsu Nakamura |
Organization
Kanazawa Medical University
Division name
Gastroenterology
Zip code
Address
1-1 Daigaku, Uchinada, Kahoku, Ishikawa
TEL
076-286-2211
mnakamur@kanazawa-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Masakatsu Nakamura |
Organization
Kanazawa Medical University
Division name
Gastroenterology
Zip code
Address
1-1 Daigaku, Uchinada, Kahoku, Ishikawa
TEL
076-286-2211
Homepage URL
mnakamur@kanazawa-med.ac.jp
Sponsor or person
Institute
Kanazawa Medical University
Institute
Department
Personal name
Funding Source
Organization
Kanazawa Medical University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 11 | Month | 22 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2013 | Year | 08 | Month | 31 | Day |
Date of IRB
Anticipated trial start date
| 2013 | Year | 11 | Month | 25 | Day |
Last follow-up date
Date of closure to data entry
| 2015 | Year | 09 | Month | 30 | Day |
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2013 | Year | 11 | Month | 22 | Day |
Last modified on
| 2016 | Year | 03 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014482
